Assuming no growth in Verio strips, UBI could be looking at a $60m payout from Lifescan in FY18 if the option is exercised.
However, what is the risk Lifescan tank their Verio strip production in FY18 to minimise their payment? Is it worth the risk to their business?
Add to My Watchlist
What is My Watchlist?
